Evo 2 Predicts Cardiomyopathy-Associated Variants and Elucidates Their Underlying Mechanisms
Atsumasa Kurozumi, Naoto Otsuka, Ito Masamichi, Toshinaru Kawakami, Takayuki Isagawa, Satoshi Kodera, N O R I H Takeda
This paper evaluates Evo 2's ability to predict pathogenicity and mechanisms of cardiomyopathy variants, showing high accuracy and structural feature identification.
bioRxiv · May 17, 2026 · PreprintGenomics